Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Launched By Crazy Bulk' Steroids Alternatives for Cutting, Bulking, Body Building & Muscle Growth Safe Oral Steroids For ...

In the weeks before the just-completed Games in London, those testers buzzed about a brand-new test they'd developed to track down athletes who take human growth hormone. David Howman, the director ...

For the second-straight season, one of Atlanta's key hitters received a suspension from MLB.

Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...

Add Yahoo as a preferred source to see more of our stories on Google. MIT engineers used a language model to pick yeast-friendly codons, boosting production of six proteins, including trastuzumab.

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

After 16 weeks of testing, we noticed visible results. Here are our favorite red light therapy devices for hair growth.

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.